Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.
Humberto Martínez-CorderoCamila PeñaNatalia Paola SchutzVirginia BoveFiorella VillanoCecilia BeltranJaviera DonosoHernán López-VidalMacarena Alejandra Roa SalinasPablo SotoPaola OchoaPatricio DuarteGuillermina RemaggiAriel CorzoClaudia ShanleySergio LoprestiSergio OrlandoVerónica VerriLuis Darío QuirogaDorotea FantlJhoanna RamirezAlejandro Ospina-IdárragaHenry IdroboGuillermo QuinteroRigoberto GomezOmar Cantu-MartinezGuillermo José Ruiz ArgüellesGuillermo José Ruiz-ArguellesKenny Mauricio Galvez-CárdenasLuis Antonio SalazarIsabella Novoa-CaicedoMaría Cynthia Fuentes-LacouturePaola SpirkoMaría Isabel ArbeláezMario PereiraJaime ValdesJule VasquezAlana Von GlasenappEloísa Rivanull nullPublished in: JCO global oncology (2023)
In conclusion, younger patients with MM in Latin America have similar clinical characteristics, responses, and OS compared with the elderly.